عربى
English
Report a side effect
Contact Us
Who We Are
Who We Are
EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
Overview
Vision, Mission & Values
Our History
Chairman Message
News and Media
Press Releases
Media Library
Sustainability & CSR
Manufacturing Facilities
Manufacturing Facilities
EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Overview
Factory 1
Factory 2
Factory 3
Eiaco Factory
Eipico Plastic Factory
Industry Expansion
Science & Medicine
Science & Medicine
EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
Products
Products (Alphabetical)
R&D and Quality
Global Accreditation
Regulatory Affairs
Global
Global
EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
Overview
Our Export History
Eipico Destination
Investor Relations
Investor Relations
Investor Relations
Annual Reports
EIPICO 3
EIPICO 3
The First Modular Biological and Biosimilar Facility in Egypt
EIPICO 3 (Biologicals & Biosimilars)
We're sorry, but our website doesn't work properly without JavaScript enabled.
1
Who are you
2
Product
3
Side Effect
4
Patient
5
Contact Details
6
Summary
Country
*
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Côte d'Ivoire
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo (Congo-Brazzaville)
Costa Rica
Croatia
Cuba
Cyprus
Czechia (Czech Republic)
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (fmr. "Swaziland")
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Holy See
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar (formerly Burma)
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
North Macedonia
Norway
Oman
Pakistan
Palau
Palestine State
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Who are you?
*
Member of public (eg. yourself, a patient, friend, parent or carer)
Health care provider (HCP)
Product name
*
Active Ingredient
*
How is this medicine related to the side effect?
*
Suspected
Used for treatment of the side effect
Concomitant
When did the person experiencing the side effect start taking the medicine?
*
Start Date
End Date
Why did they take this medicine?
Which formulation of the medicine were they taking?
Ampoule
Caplet
Capsule
Chewable Tablet
Cream
Dispersible Tablet
Drop
Dry Powder
Ear Drops
Emulgel
Enteric Tablet
Extended Release Capsules
Extended Release Tablet
Eye Drops NOS
Eye Gel NOS
Eye Ointment
Film-Coated Tablet
Gel
Gel Capsules
Granulate
Hard-Gelatin Capsule
Inhaler
Liquid
Lotion
Nasal drop
Nasal spray
Ointment
Orodispersible Film
Patch
Powder
Slow Release Capsules
Slow Release Granule
Slow Release Tablet
Solution
Solution for Infusion
Solution for Injection
Spray
Sugar-coated Tablet
Suppository
Suspension
Syrup
Tablet
Trans-therapeutic-system
Unknown
Vial
How did they take it?
*
Cutaneous
Inhalation
Intramuscular
Intrathecal
Intravenous
Nasal
Ophthalmic
Oral
Parenteral
Rectal
Subcutaneous
Sublingual
Topical
Transdermal
Transplacental
Unknown
Vaginal
Other
What dose were they taking?
*
mg (milligram)
µg (microgram)
mg/kg(miligram/kilogram)
Gtt (drop)
DF(Dosage Form)
kg (kilogram)
g (gram)
ml(mililitre)
%(percent)
µg/kg(microgram/kilogram)
µl (microlitre)
Mbq(mecabequeral)
mol(mole)
mmole(milimole)
µmole(micromole)
iu (international unit)
Other Dosage [e.g. 24/26 mg or other]
How often did they take it?
Once daily
Twice a day
Three times a day
Four times a day
Every Evening
Every 12 hours
Every 48 hours
Every 72 hours
Every other day
Once a week
Once every two weeks
Once a month
One single dose
As needed
Other
What action was taken with the medicine as result of the side effect?
*
Dose reduced
Dose increased
No change
Treatment discontinued
Unknown
Batch number:
Side Effect
*
What was the outcome of the side effect?
*
Complete recovery
Condition deteriorated
Condition improving
Condition Unchanged
Fatal or death
Recovered with sequelae
Unknown
How long did the patient experience the adverse event?
*
Start Date
End Date
Please provide below if you consider there is a causal relationship between the event and the suspect product(s) and/or any additional detail(s) for the event(s) or treatment(s)
Was the side effect serious?
*
Unknown
No, it was not serious
Yes, it was serious
How serious was the side effect?
Resulted in death
Was life threatening
Resulted in or prolonged hospitalization
Resulted in a disability or was incapacitating
Resulted in a congenital anomaly or birth defect
Medically Significant
About the person experiencing the side effect
Gender
*
Male
Female
What are the initials of the person?
Age
*
Years
Months
Days
Height
Centimeter
Feet
Weight
kilogram
Pounds
Date of birth
Patient’s medical history
Please provide results of tests/labs, medical history, allergies, etc:
*
Please upload any relevant documents:
Contact Reporter
Email address
Is Reporter the Patient?
Yes
No
Someone I know
A patient I support
Your title:
Mr.
Ms.
Mrs.
Dr.
First name
*
Last name
Address line 1
Address line 2
Town/City
Phone number:
*
Contact a health care professional
First name
*
Last name
Address line 1
Address line 2
Town/City
Country:
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Côte d'Ivoire
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo (Congo-Brazzaville)
Costa Rica
Croatia
Cuba
Cyprus
Czechia (Czech Republic)
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (fmr. "Swaziland")
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Holy See
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar (formerly Burma)
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
North Macedonia
Norway
Oman
Pakistan
Palau
Palestine State
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Phone number:
*
Profession:
*
Physician
Dentist
Pharmacist
Nurse
Medical Assistant
Name of hospital, clinic etc:
*
Email Address:
Adverse Event Privacy
*
I authorize EIPICo. and any of its affiliates to collect and analyze the information I provide for the purpose of assessing side effects related to my use of an EIPICo.'s product, and to disclose this information to health authorities in my country and other countries around the world as required by law or regulation. All information pertaining to this report, as well as any follow up inquiries for additional medical details, shall be in accordance with the EIPICo. patient safety reporting privacy notice.
Captcha
*